Neola Medical recently opened an office in Palo Alto, Silicon Valley, USA, ahead of the U.S. launch of the company’s medical device product Neola®, for continuous monitoring of the lungs of preterm born babies. CEO Hanna Sjöström is on site to attend the Stanford Impact1 CEO Summit after the company’s advanced medical device Neola®, was selected by Stanford’s world-leading experts as one of the most promising innovations to improve healthcare for children. See more about what this means for Neola Medical in the interview with BioStock below.

Read more about the Stanford Impact1 program in the press release: Pressmeddelande

Read more about the opening of the Neola Medical office in Silicon Valley in the press release: Pressmeddelande